ERBB2 and breast carcinoma: In line with previous research, where mRNA expression data has been consistently recognized as a key factor in identifying breast cancer subtypes, our analysis of the TCGA-BRCA dataset confirms that mRNA expression significantly contributed to the prediction of Basal-like, HER2-enriched, and Luminal A subtypes.